Sign In
Buy AMPH
$18.12
-0.330 (-1.79%)
At Close: Jun 03, 2026
Amphastar Pharmaceuticals Inc (AMPH): Hedge Funds In Wait-and-See Mode
08:17pm, Friday, 12'th Jun 2020
We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of Ma
Aerie Pharma (AERI) Received its Third Buy in a Row - Markets
12:43pm, Friday, 12'th Jun 2020
After Mizuho Securities and Oppenheimer gave Aerie Pharma (NASDAQ: AERI) a Buy rating last month, the company received another Buy,
Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference
10:30am, Friday, 12'th Jun 2020
Amphastar Pharmaceuticals, Inc. (AMPH) announced today that Bill Peters, CFO, Dan Dischner, Vice President of Corporate Communications and Human Resources, and Tony Marrs, Sr. Vice President Regulator
Top Pharmaceutical Stocks for Q3 2020
06:45pm, Thursday, 11'th Jun 2020
These are the pharmaceutical stocks with the best value, fastest growth, and most momentum for Q3 2020.
Dow Jones Today Set To Snap Win Streak, Stocks Lower As Airline Pullback: Dexcom Rallies On Price Hike
01:52pm, Tuesday, 09'th Jun 2020
Lovesac and Nikola were early risers, as airlines retreated and stock futures slipped and the Dow Jones today appeared set to snap its seven-day advance.
Amphastar’s newly approved drug product was determined by the FDA to be therapeutically equivalent to Quelicin™ (Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial)
Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
08:05pm, Tuesday, 02'nd Jun 2020
Amphastar Pharmaceuticals, Inc. (AMPH) announced today that Bill Peters, CFO and Dan Dischner, Vice President of Corporate Communications and Human Resources will be presenting at the Jefferies Virtua
Amphastar Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
12:00am, Tuesday, 02'nd Jun 2020Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2020 Results - Earnings Call Transcript
01:43am, Tuesday, 12'th May 2020
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2020 Earnings Conference Call May 07, 2020, 05:00 PM ET Company Participants Dan Dischner - VP of Corporate Com
U.S. RESEARCH ROUNDUP-Acushnet Holdings, Equity Residential, Fiserv
06:02pm, Monday, 11'th May 2020
Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Acushnet Holdings, Equity Residential and Fiserv, on
Monday.
HIGHLIGHTS
BMO Capital Maintains Market Perform on Amphastar Pharmaceuticals, Raises Price Target to $21
04:07pm, Monday, 11'th May 2020Edited Transcript of AMPH earnings conference call or presentation 7-May-20 9:00pm GMT
05:24am, Monday, 11'th May 2020
Q1 2020 Amphastar Pharmaceuticals Inc Earnings Call
Is Now The Time To Put Amphastar Pharmaceuticals (NASDAQ:AMPH) On Your Watchlist?
12:21pm, Saturday, 09'th May 2020
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of...
Edited Transcript of AMPH earnings conference call or presentation 7-May-20 9:00pm GMT
05:42am, Saturday, 09'th May 2020
Q1 2020 Amphastar Pharmaceuticals Inc Earnings Call
